<?xml version="1.0" encoding="UTF-8"?>
<p>Hyaluronic acid (HA) has also been approved for use in injections by the U.S. Food and Drug Administration (FDA). It is a mucoadhesive, biodegradable, and biocompatible polysaccharide having a negative charge. Hyaluronan was first used as a substitution/ replacement for vitreous humor during surgeries of the eyes during the late 1950s. Polymers of HA are usually applied in gel preparations for drug delivery in eyes or other optical cavities. Corneal shields made from HA are known to demonstrate prolonged delivery of steroids along with a quintessential dosage profile smoothing [
 <xref rid="B113-polymers-13-01242" ref-type="bibr">113</xref>]. Apart from these, there are various other uses of HA as observed by Fakhari and Barkland, 2013 [
 <xref rid="B114-polymers-13-01242" ref-type="bibr">114</xref>], are described below:
 <list list-type="roman-upper">
  <list-item>
   <p>Epithelial regeneration</p>
  </list-item>
  <list-item>
   <p>Extracellular regeneration leading to wound healing</p>
  </list-item>
  <list-item>
   <p>Agent of viscosity in pulmonary diseases to achieve alveolar patency</p>
  </list-item>
  <list-item>
   <p>Topical medicinal treatment for treating Sjogrenâ€™s syndrome (dry eye syndrome) [
    <xref rid="B115-polymers-13-01242" ref-type="bibr">115</xref>]
   </p>
  </list-item>
  <list-item>
   <p>Regenerative medicinal filler to cure cutaneous lines and wrinkles</p>
  </list-item>
  <list-item>
   <p>Commercial formulations to be used in intra-articular injections</p>
  </list-item>
 </list>
</p>
